Medtech Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Gliatech hires outsider for corrective actions:

This article was originally published in Clinica

Executive Summary

Gliatech has hired an external auditor for corrective actions and future filings to the FDA under the regulator's Application Integration Policy (AIP). Gliatech recalled its Adcon-L anti-adhesion gel in January following possible contamination and was placed on a special FDA AIP watch list following earlier post approval trials which were conducted unacceptably (see Clinica No 943 p 11).

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT070149

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel